What's in Connect Biopharma Australia Pty Ltd's pipeline?

Connect Biopharma Australia Pty Ltd has 3 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with Connect Biopharma Australia Pty Ltd's portfolio?

Top competitors by shared drug class: Bayer, Bayer AG, Carolina Eyecare Physicians, LLC, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Daewon Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/connect-biopharma-australia-pty-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Connect Biopharma Australia Pty Ltd — Portfolio Competitive Intelligence Brief

Connect Biopharma Australia Pty Ltd pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Moxifloxacin (Avelox)	Moxifloxacin (Avelox)	marketed	Fluoroquinolone antibiotic	DNA gyrase; Topoisomerase IV	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Bayer AG · 1 shared drug class
Carolina Eyecare Physicians, LLC · 1 shared drug class
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 1 shared drug class
Daewon Pharmaceutical Co., Ltd. · 1 shared drug class
Fundacion Clinic per a la Recerca Biomédica · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Connect Biopharma Australia Pty Ltd:

Cite this brief

Drug Landscape (2026). Connect Biopharma Australia Pty Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/connect-biopharma-australia-pty-ltd. Accessed 2026-05-16.